[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng, X Wang - Frontiers in Immunology, 2023 - frontiersin.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy.

X Wang, Y Zhang, Y Wu, H Cheng - Frontiers in Immunology, 2023 - europepmc.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng, X Wang - 2023 - europepmc.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …